ChartRow logo
Share this page
NVO
$38.26+1.95%
as of close, Oct 7, 2026
☾ AH $38.26 +1.95%
PeersMRNALLYUNHJNJMDTMRK

NVO — Novo Nordisk A/S price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in NVO be worth today? →
NVO returns: By year · By month · By week · Trailing

Key stats#

Price data

Price
$38.26
YTD price return
-24.80%
YTD total return
-21.05%
Next earnings
Nov 4, 2026
Market cap
170B
Enterprise value
184.9B
Shares outstanding
4.4B
52W low
$35.12
52W high
$64.16
From 52W high
-40.37%
From 52W low
+8.94%
52W range
11%
Beta
0.74

Volume

Rel volume
1.02×
30D volume
13.2M
30D $ vol
543.5M

Fundamentals

Sales (ttm)
46.6B
Sales/share
$10.50
EPS (ttm)
$3.48
FCF (ttm)
18B
FCF/share
$4.05
Book value/share
$6.87
Net margin
33.14%
ROE
50.62%
ROA
18.09%
Debt / equity
0.57×
Current ratio
0.80

Growth (CAGR, ttm) · 10Y

Sales
+10.85%+23.09%+19.16%n/a
Net income
+5.65%+25.36%+19.13%n/a
Shares
+0.07%-0.42%-1.11%n/a

Per-share growth (CAGR, ttm) · 10Y

EPS
+6.00%+26.25%+20.34%n/a
Sales/share
+10.78%+23.60%+20.51%n/a
Book value/share
+52.70%+37.05%+25.46%n/a
Dividend/share
+6.90%+26.31%+20.47%n/a
Price
-35.19%-25.37%-4.90%+6.47%
Total return
-31.96%-23.18%-2.75%+8.89%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
11.0×
P/OI (ttm)
8.8×
Fwd P/E
11.2×
P/S (ttm)
3.6×
P/B (mrq)
5.6×
P/FCF (ttm)
9.5×
EV/EBITDA (fy)
8.6×
EV/Sales (ttm)
4.0×
FCF yield (ttm)
10.57%
Dividend yield (ttm)
4.85%
Buyback yield (realized, 1y)
-0.07%
Shareholder yield (realized, 1y)
1.98%
Buyback yield (cash, ttm)
0.12%
Shareholder yield (cash, ttm)
4.72%

Vs own 10Y history

P/E
2nd
P/OI
2nd
P/S
2nd
P/B
2nd

Bar = where today’s multiple sits in NVO’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-07#

1D
+1.95%
5D
+0.92%
1M
-17.90%
3M
-22.93%
YTD
-24.80%
1Y
-35.17%
5Y
-22.22%

Recent filings#

No earnings release, press release or insider trade outside a 10b5-1 plan in the last 120 days.

All filings and insider trades →

Financial statements

Open full NVO financials →
Loading financial statements…
TickerName1M1D
NVSNovartis AG-10.44%+1.77%
SNYSanofi ADS-9.13%+1.62%
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)-5.75%+0.90%
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)-0.43%+1.49%
ARGXargenx SE American Depositary Shares-10.14%-0.22%
NTRANatera Inc.+20.53%-1.27%
TEVATeva Pharmaceutical Industries Limited American Depositary Shares+7.76%+0.13%
RVMDRevolution Medicines Inc.-4.36%+0.50%